Evidence/Findings:
Based on record review, observation, and interview, the manager failed to ensure a medication administered to a resident was documented in the resident's medical record for two of two residents sampled. The deficient practice posed a risk of a potential adverse reaction or outcome with an error in administering a residents medication.
Findings include:
1. A review of R1's medical record revealed a service plan dated December 14, 2022. The service plan revealed R1 received medication administration.
2. A review of R1's medication administration record (MAR) revealed R1 received Pravastatin 80 milligrams (mg) every morning.
3. A review of R1's medical record revealed a medication order signed by a medical practitioner, dated February 28, 2023 for Pravastatin 80 mg every evening.
4. A review of R1's medications revealed a medication bottle containing Pravastatin 80 mg with instructions to administer every evening. The compliance officer observed Pravastatin in the evening slot of R1's medication organizer.
5. In an interview, E1 acknowledged the Pravastatin was not correctly documented in R1's MAR. E1 reported R1 received the medication as ordered.
6. A review of R2's medical record revealed a service plan dated November 25, 2022. The service plan revealed R2 received medication administration.
7. A review of R2's medical record revealed a medication list signed by a medical practitioner, dated April 28, 2023. The medication list included Furosemide 20 mg, one tablet on Sunday, Monday, Wednesday, and Friday.
8. A review of R2's medications revealed a medication bottle containing Furosemide 20 mg with instructions to administer Sunday, Monday, Wednesday, and Friday. The compliance officer observed Furosemide in R2's medication organizer on the appropriate days.
9. A review of R2's MAR revealed R2 received Furosemide every day in April 2023 and every day from May 1, 2023 to May 11, 2023.
10. In an interview, E1 acknowledged the Furosemide was documented correctly as being administered on Sunday, Monday, Wednesday, and Friday. However, E1 reported R2 received the medication as ordered.
11. A review of R2's medical record revealed a medication list signed by a medical practitioner, dated April 28, 2023. The medication list included Hydroxyzine 25 mg, one tablet three times a day.
12. A review of R2's medications revealed a medication bottle containing Hydroxyzine 25 mg. The compliance officer observed Hydroxyzine in R2's medication organizer.
13. A review of R2's medical record revealed a MAR dated May 2023. However, Hydroxyzine 25 mg was not listed on the MAR.
14. In an interview, E1 acknowledged the Hydroxyzine administered to R2 was not documented in R2's medical record. E1 reported R2 received the Hydroxyzine as ordered. However, the administration of the aforementioned medication was not documented in the MAR as required. E1 reported R2 has gone off and on the medication several times, and it mistakenly did not get transferred to the MAR.
15. A review of R2's medical record revealed a medication list signed by a medical practitioner, dated April 28, 2023. The medication list included Celexa (Citalopram) 10 mg, one tablet at bedtime.
16. A review of R2's medical record revealed a MAR dated May 2023. Citalopram was listed on the MAR as being administered each day in the morning.
17. A review of R2's medications revealed a medication bottle containing Citalopram 10 mg. The bottle directed the Citalopram to be administered at bedtime.
18. A review of R2's medications revealed the Citalopram was in the bedtime slot.
19. In an interview, E1 acknowledged the Citalopram was not getting documented correctly as being administered at bedtime. However, E1 reported R2 received the medication as ordered.
20. A review of R2's medical record revealed a medication list signed by a medical practitioner, dated April 28, 2023. The medication list included Clonidine 0.2 mg, one tablet daily as needed (PRN) for Systolic Blood Pressure (SBP) > 170 mmHg, re-check BP after receiving PRN dose.
21. A review of R2's MAR revealed R2 received Clonidine 0.2 mg daily from April 1, 2023 to May 11, 2023.
22. Further review of R2's medical record revealed the following blood pressure readings on the following dates:
-April 10, 2023: 154/40;
-April 11, 2023: 161/50;
-April 12, 2023: 159/41;
-April 13, 2023: 158/39;
-April 13, 2023: 133/89;
-April 14, 2023: 156/46;
-April 15, 2023: 151/79;
-April 16, 2023: 162/58;
-April 17, 2023: 172/88;
-April 20, 2023: 148/62;
-April 22, 2023: 147/79;
-April 23, 2023: 137/79;
-April 24, 2023: 136/78;
-April 25, 2023: 162/56;
-April 28, 2023: 151/91;
-April 29, 2023: 179/99;
-April 30, 2023: 171/86;
-May 1, 2023: 137/88:
-May 2, 2023: 150/72;
-May 8, 2023: 149/89
-May 9, 2023: 190/127;
-May 9, 2023: 120/73;
-May 10, 2023: 139/73; and
-May 11, 2023: 129/81.
23. In an interview, E1 acknowledged (based on the blood pressure readings), R2 should have received Clonidine 10 mg only on the following four occasions:
-April 17, 2023;
-April 29, 2023;
-April 30, 2023; and
-May 9, 2023.
24. In an interview, E1 reported R2 did not receive Clonidine daily as recorded on R2's MAR. E1 reported the caregivers just "followed suit" when documenting medication administration and incorrectly documented R2's medication as received daily.
Summary:
No deficiencies were found during the off-site modification for an increase in occupancy from four to five residents, completed on February 7, 2024.